Clinical trial
Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors
NCT02313012
Study timeline
Study start (actual)2015-01-05Date precision: day
Registry last updated2019-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasm Metastasisunresolved
Interventions
CC-90003DRUG
Sponsors & collaborators
Celgenelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02313012 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.